Clinical Trial Update: A Phase 1 Study to Examine the Drug-Drug Interaction of Ciprofloxacin, Itraconazole, and Rifampin on the Combination of Lumacaftor With Ivacaftor in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study evaluating potential drug-drug interactions between lumacaftor/ivacaftor and ciprofloxacin, itraconazole, and rifampin in health…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Ciprofloxacin (Ciprofloxacin hydrochloride)
• Itraconazole (Itraconazole)
• ORKAMBI (lumacaftor and ivacaftor)
• RIFAMPIN (RIFAMPIN)

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Cystic Fibrosis | Phase 1 | Status: COMPLETED